Clinical Trials Directory

Trials / Completed

CompletedNCT01293331

Study of Febrile Illness for Dengue-Endemic Areas in Latin America

Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Latin America

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Sanofi · Industry
Sex
All
Age
9 Years – 16 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to detect acute febrile episodes and dengue infection in five Latin American countries to assess dengue seroprevalence. Primary objectives: * To identify acute febrile episodes among the cohort in order to detect the presence of dengue infection. * To describe the dengue seroprevalence among the cohort at baseline and at the end of the study.

Detailed description

All participants will make two visits to a study site, an enrollment visit and a termination visit. Additional visits will be made if febrile episodes occur: an acute visit and a convalescent visit. Participants or their parents/guardians will be contacted weekly to monitor the occurrence of febrile episodes and ensure appropriate assessment and care. No vaccine will be provided or administered in this study

Conditions

Timeline

Start date
2010-08-01
Primary completion
2011-12-01
Completion
2012-04-01
First posted
2011-02-10
Last updated
2015-06-17

Locations

18 sites across 4 countries: Brazil, Colombia, Mexico, Puerto Rico

Source: ClinicalTrials.gov record NCT01293331. Inclusion in this directory is not an endorsement.